CMAT

CMAT: CARDIO-METABOLIC ASSESSMENT TEST

Prime Health Solutions, medical treatment, medical solutions, CMAT, cardiovascular disease, heart disease, heart disease testing, Cardiovascular health

 WHAT IS CMAT?

HEART DISEASE TESTING

CMAT stands for Cardio-Metabolic Assessment Test. The CMAT is an innovative platform that provides you, as a physician, with valuable information regarding Cardio-Metabolic risk, the autonomic nervous system and the potential degradation of function resultant from chronic health conditions such as Diabetes, Atherosclerosis, Autonomic Nervous System Dysfunction and many other conditions.

Cardio-Metabolic Assessment Testing includes a broad set of tests that provides detailed insight into your cardiovascular health by defining your true risk for cardiovascular disease, Type 2 Diabetes, and vascular inflammation, which in turn breeds disease throughout the body.  

These tests will help you understand how cardiovascular disease isn't just caused by one single factor, but rather a constellation of factors that contributes toward the development of cardiovascular disease, diabetes and inflammation. These are factors that can be controlled and changed. 

Just simply testing cholesterol alone is outdated and completely uninformative as a screening tool for cardiovascular disease. The Cardio-Metabolic panel of tests will arm you with extensive insight into your health.

Heart disease can strike anyone, even extremely fit athletes. These tests will provide you with detailed information regarding the extent to which heart disease, or its beginnings, may be present. You can then use this information to take preventive action if needed, or assurance that you're on the right track.  

Key components of the Cardio-Metabolic Test include:
  • Lipoprotein Fractionation   
  • Lipoprotein Particle Numbers
  • Total Cholesterol
  • HDL Cholesterol
  • LDL Cholesterol
  • Triglycerides
  • Homocysteine
  • Lipoprotein (a)
  • Apolipoprotein A-1
  • Apolipoprotein B
  • Omega Check
  • Cardio-Metabolic Risk Assessment
  • Type 2 Diabetes Assessment
  • Estimated Average Glucose (eAG)
  • Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)
Part of the Cardio-Metabolic panel includes pre-Diabetes testing. These tests identify metabolic abnormalities that can lead to Type 2 Diabetes. Pre-diabetes is a common condition wherein the body cannot metabolize carbohydrate foods properly, resulting in impaired blood glucose control, which in turn can progress to diabetes if not properly addressed through diet and lifestyle changes. 

APPOINTMENTS

 Did you know:  The CDC report that 4.0 percent of people aged 18 to 44 years are living with diabetes, 17 percent of those aged 45 to 64 years, and 25.2 percent of those aged over 65 years.

WHAT DOES THE CMAT DO?

CARDIOVASCULAR DISEASE

The CMAT assesses the broad functionality of the autonomic nervous system in a few short minutes, revealing critical clinical data that supports the earliest possible diagnosis and treatment of secondary concerns related to health conditions like erratic blood glucose, PAD, CAN, PN and ANS balance.

The goal of the CMAT exam is to provide a physician with the following: 
  • A new tool to evaluate patient symptoms and complications associated with chronic disease.
  • A new tool for the early detection of chronic diseases, such as Type 2 Diabetes and Vascular Disease.
  • A method of risk stratification as we move toward value-based medicine.

Prime Health Solutions, medical treatment, medical solutions, CMAT, cardiovascular disease, heart disease, heart disease testing, Cardiovascular health

HOW SHOULD THE DEVICE BE

USED IN A CLINICAL SETTING?

HEART DISEASE SYMPTOMS

Our vision is to provide physicians with new tools and a better approach to detect and treat Diabetes and its complications. Diabetes is NOT ONLY a blood glucose level concern, but it's also a chronic disease that damages the autonomic nerves and micro/macrovascular systems.

Unfortunately, current laboratory exams are incomplete markers for the early detection of Diabetes and its complications, and for assessing the full effectiveness of treatment. In adjunct with the laboratory tests, our products aim to provide better solutions to improve patient outcomes that will benefit the overall care of patients.

HOW DOES THE CMAT SIMPLIFY

MY COMPLEX DECISIONS?

CARDIOVASCULAR TESTING

 The CMAT-Advantage System includes the following tests to determine these clinical outcomes and comprises:
  • Sudomotor Function Tests: Using sympathetic skin response via disposable electrodes, following a predetermined double sympathetic stimulation (electrical and metaboreflex), not patient or operator dependent, in order to get reproducible results.
  • Volume Plethysmography Analysis: From the oscillometric method, in order to calculate the brachial ankle pulse wave velocity and peripheral Augmentation Index Ratio.
  • Cardiac Autonomic Reflex Tests or Ewing Tests: Using the photoplethysmography analysis to accurately detect the beat-to-beat heart rate during the Valsalva Maneuver, Deep Breathing Exercising and Postural Changes. 
  • Ankle Brachial Index (ABI) and optional Toe Brachial Index (TBI): Using the oscillometric method and volume plethysmography at 2 levels. 

Prime Health Solutions, medical treatment, medical solutions, CMAT, cardiovascular disease, heart disease, heart disease testing, Cardiovascular health

Did you know:  5 Things a Comprehensive Metabolic Panel Can Uncover:

1. Kidney and liver function  2. Blood sugar  3. Calcium levels 

4. Sodium, potassium and chloride levels (electrolytes)  5. Protein levels

Prime Health Solutions, medical treatment, medical solutions, CMAT, cardiovascular disease, heart disease, heart disease testing, Cardiovascular health

THE RESULTS OF THE CMAT-ADVANTAGE SYSTEM COULD BE SENT TO A SERVER OR EMR, OR A SECURED CLOUD, AFTER REGISTRATION. 

ADA and AHA Guidelines state that an ANS System imbalance assessment is necessary. Also, vascular and neural diseases are closely related and intertwined, so blood vessels depend on normal nerve function and the nerves depend on adequate blood flow.

Not infrequently, physicians face patients who have chronic metabolic disease or other comorbid conditions and symptoms. At times, differentiating vascular from neuropathic disorder can be difficult. It’s imperative to distinguish between autonomic neuropathy and vascular disease because the treatments are quite different. 

The opportunities to have a clinically relevant test for CVD and diabetic risks, and provide an additional profit center, are valuable additions for your practice. For more information about the CMAT-Advantage or to schedule a FREE clinical demonstration, contact Prime Health Solutions USA today.

Share by: